Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
Single-Cell Cloning Remains a Challenge
Evolving Technologies Help Make It Easier to Meet Regulatory Requirements
Another "CRISPR Calamity"? U.K. Team Reports CRISPR-Induced Gene Rearrangements
New Findings Call the Precision of CRISPR-Cas9 Gene Editing into Question
Cannabinoid-Based Drugs Seek New High, Part I
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
For full access to this article login to GEN Select now.
Managing Asthma and COPD Treatments
Delivery and Patient Compliance Are Central to Asthma, while New Therapies Are Key to COPD
- Asthma and chronic obstructive pulmonary disease (COPD) are becoming more common throughout the world especially in countries such as India and China. So the potential for treating these diseases is enormous, said Peter Barnes, head of respiratory medicine, Imperial College, London (www3.imperial.ac.uk), at the recent SMI conference on “Asthma ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.